|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:660-667
© 2002 The American Association for Thoracic Surgery
General Thoracic Surgery (GTS) |
From the Division of Thoracic Surgery,a Tor Vergata University, and the Department of Experimental Medicine and Pathology,b La Sapienza University, Rome, Italy.
The Pulmonary Emphysema Research Group is supported by grant 9906274194-06 of Ministero dell'Università e della Ricerca Scientifica e Tecnologica and partially by CNR n. CU0100935CT26 2002.
Received for publication Oct 1, 2001. Revisions requested Dec 7, 2001; revisions received Jan 11, 2002. Accepted for publication Jan 23, 2002. Address for reprints: Tommaso Claudio Mineo, MD, Cattedra di Chirurgia Toracica, Università Tor Vergata, Policlinico Tor Vergata, Via Oxford, 81, 00133 Rome, Italy (E-mail: mineo{at}med.uniroma2.it).
| Abstract |
|---|
|
|
|---|
= -0.437, P = .02) and residual volume reduction (
= -0.446, P = .01). Total proteins (P = .003), albumin (P = .03), transferrin (P = .04), cholesterol (P = .003), hemoglobin (P = .01), triceps skin fold measurement (P < .0001), and midarm muscle circumference (P < .0001) were significantly increased only in the reduction pneumoplasty group. Conversely, in the respiratory rehabilitation group no nutritional index was significantly increased at 6 months after rehabilitation. | Introduction |
|---|
|
|
|---|
|
In recent years reduction pneumoplasty (RP), a palliative surgical procedure that involves resection of 20% to 30% of the lung volume, has been demonstrated to improve lung function, exercise capacity, and subjective dyspnea in properly selected patients with COPD.
7 Body weight has been also reported to improve after RP,
8 although this effect is inconsistent
9 and not yet well explained. Even less information is available regarding changes in nutritional status. We hypothesized that RP might improve weight gain and nutritional status and that this effect would probably be due to physiologic improvements induced by the operation itself.
We have already shown in a prospective, randomized, controlled study that sole RP is superior to respiratory rehabilitation (RR) in improving lung function, muscle strength, and exercise capacity.
10 We have since studied in the same series of patients the impact of RP relative to maximal medical therapy, including RR, in determining improvements of body weight and nutritional status.
| Methods |
|---|
|
|
|---|
|
|
Nutritional assessment
The nutritional assessment included the following: dietary history, physical examination, anthropometric measurements, and biochemical measurements including total protein, albumin, calcium, magnesium, phosphate, hemoglobin, transferrin, and cholesterol blood levels. The dietary history incorporated a 24-hour recall in which the patient described the food eaten during the previous 24 hours or on a typical day, plus a food frequency list. A trained dietician collected the information. On physical examination, typical signs of nutritional deficiency were looked for and noted when present. Anthropometric measures consisted of weight, height, arm circumference, and skin fold thickness determination. Anecdotal reports of weight before development of symptoms were also investigated. Body weight was measured to the nearest 0.1 kg with a beam scale, and body height was measured to the nearest 0.5 cm with the patient standing barefoot. The body mass index (BMI, in kilograms per square meter) was then calculated from weight (in kilograms) and height (in meters) as weight/height
2. Triceps skin fold thickness and midarm muscle circumference (equal to midarm circumference[triceps skin fold thickness x 0.314]) were assessed by the same skilled dietician according to the standardized techniques.
13 These measurements were compared with normal values and expressed as predicted percentages obtained with the standard percentiles.
14 Body composition was measured by 5-frequency (1, 5, 10, 50, and 100 kHz) bioelectric impedance analysis (Human IM Scan, Dietosystem; DS Group, Milan, Italy) with the subject in a fasting state, relaxed, and lying in the supine position. Fat mass (FM) and fat-free mass (FFM) were calculated by the conduction of an electric current through the body, according to the software Impedenziometria Plus (version 1.55; DS Group). Body weight, anthropometric measurements, body composition, and nutritional assessment were repeated along with the functional measurements 3 and 6 months after treatment and, when possible, again at 12 months.
Surgical technique
The operation was directed toward reducing 20% to 30% of the lung volume by excising functionally useless and hyperinflated lung tissue. Patients assigned to the surgical arm underwent tailored unilateral or bilateral RP. The main indication for unilateral RP was the finding of an asymmetric distribution of emphysema between the lungs (Table 1
).
15 Staple resection of target areas was routinely performed, excising a single strip of lung tissue. Patients were routinely extubated in the operating room.
Respiratory rehabilitation
The outpatient rehabilitation program was directed toward optimizing the ability to perform daily living activities by improving exercise capacity. It entailed 3-hour supervised sessions 5 days per week for at least 6 weeks. The first half of each session included educational activities, such as breathing retraining, chest clearance, energy conservation, nutritional and medication education, and psychosocial support. The second half of each session entailed physical conditioning, including inspiratory resistive exercises, upper extremity training, and lower extremity training.
Study design and statistical methods
The trial was designed as prospective, randomized, controlled study with transverse and longitudinal evaluations (Figure 1
). The transverse evaluation outlined a comparison 6 months after treatment between the patients who had been subjected solely to RP and a control group of patients with homogeneous features who underwent sole RR. Longitudinal evaluation included measurement of the same subject before and 6 months after treatment. Trial duration was set at 6 months on the assumption that for either treatment peak improvements should be reached within the first 6 months. Such a limited duration of the trial was also preferred for ethical purposes, to allow eventual crossover of patients without improvement to the most effective therapy after final follow-up evaluation. Incidental 12-month data were also collected where available, which did not change group. Trial size was considered significant, as noted in a previous report involving the same study population.
10 Group descriptive statistics were presented as mean ± SD. Because of the nonnormal distribution of the data and the limited sample size, the Wilcoxon rank-sum test and the Mann-Whitney test were used for paired and unpaired data, respectively.
Changes in oxygen and steroid use were assessed by means of McNemar and
2 tests as indicated. To determine whether changes in pulmonary function were correlated with weight or nutritional status, we performed the Spearman nonparametric correlation (SPSS 9.05 for Windows, SPSS Inc, Chicago, Ill) of the percentage changes in individual parameters of lung function and percentage changes in body weight and nutritional indices. Data were expressed with the
coefficient.
| Results |
|---|
|
|
|---|
|
|
Table 2
illustrates symptomatic, functional, and exercise results observed in the two groups at 6 months. Significant longitudinal improvements were found in both groups, whereas after RR some functional parameters (forced expiratory volume in 1 second, RV, and total lung capacity) did not improve. At the 6-month comparison, the RP group scored significantly better than the RR group in all parameters considered except maximal inspiratory pressure at RV, maximal expiratory pressure at total lung capacity, and PaCO2, in all of which statistically nonsignificant improvements were nonetheless recorded.
Despite the lack of significant changes in energy intake, body weight had significantly different trends in the two groups (P < .0001). In the RP group, we found a constant gain relative to baseline values, with changes of 1.82 ± 2.63 kg (range -4 to 6 kg) at 3 months (P = .004) and 2.87 ± 3.76 kg (range -8 to 9 kg) at 6 months (P = .002), with an absolute mean value of 68.4 ± 9.94 kg. In terms of percentage from baseline, the gain at 6 months was 4.77%. According to the data available from 24 patients at 1 year, mean weight gain was 3.29 ± 4.01 kg from the baseline (range -7 to 10 kg, P = .002). All but 5 patients gained weight after 12 months. Low body weight was significantly correlated with the percentage of weight gain at 6 months (
= -0.437, P = .02); the lower the baseline was, the greater was the observed gain. There was no significant difference in 6-month weight gain between patients who underwent unilateral and bilateral RP in either mean values (2.16 ± 4.15 kg vs 3.40 ± 3.50 kg, P = .4) or the number of patients who gained weight (8 vs 12).
In the RR group, the patients did not show any weight gain from the preoperative value. Mean weight changes were -0.57 ± 2.25 kg at 3 months and -1.11 ± 2.64 kg at 6 months, with a percentage change of -1.45% from the baseline. One-year results were available for 19 patients, and weight change was -0.95 ± 1.90 kg (-1.39%).
Variations in BMI followed the same trend as body weight (-1.45% of the basal value), with a significant difference between the two groups (P < .0001). There was a correlation between higher percentage of weight gain and lower baseline BMI (
= -0.385, P = .04).
Changes in the indices of nutritional status are reported in Table 3
. Both FM and FFM increased after surgery, but only FFM had a significant improvement (P = .001). In contrast, after rehabilitation FFM decreased significantly (P = .03), whereas FM did not change much. Significant increases were seen at 6 months after the operation in total proteins (P = .003), transferrin (P = .04), cholesterol (P = .003), hemoglobin (P = .01), triceps skin fold thickness (P < .0001), and midarm muscle circumference (P < .0001). In contrast, no significant changes in the variables studied were found in the RR group. Comparison of RP and RR groups showed statistically significant improvements in the RP group in all indices except FM, blood glucose, and total proteins.
In the RP group, there was a significant positive correlation between 6-month weight gain and improvement in RV (
= -0.446, P = .01; Table 4), whereas no significant correlation was found with forced expiratory volume in 1 second, maximal inspiratory pressure measurement at RV, 6-minute walk test, forced vital capacity, total lung capacity, PaO2, PaCO2, and incremental treadmill test (data not shown). Correlation with RV was demonstrable for FFM and FM percentage changes (Table 4
). No changes in serum biomarkers were significantly correlated with functional tests, subjective tests, and steroid weaning. No correlation between either body weight or nutritional status and functional tests was demonstrable in the RR group.
|
| Discussion |
|---|
|
|
|---|
In a previous article
10 on the same patient population, we showed that short-term improvements in dyspnea index, Pao2, inspiratory muscle strength, and exercise capacity occurred after both RP and RR. We also showed that dyspnea index, PaO2, and exercise capacity improved more after RP than after RR, whereas pulmonary function and oxygen requirement improved only after RP. Criner and colleagues
16 and Geddes and associates
17 recently demonstrated in two different randomized studies that RP may provide immediate improvement of static volumes and quality of life that is more prolonged than any benefit from maximal medical therapy, including RR. Hypothetic mechanisms of improvement include reduced thoracic hyperinflation and reduced mechanical constraints on lung volume expansion, both of which are related to a reduction in RV.
18,19 These mechanisms may represent a possible explanation of the greater improvement in symptoms that we have observed after RP, because pulmonary function measures and static lung volumes did not change after RR.
The significant impact of RP on body weight might be explained on the same basis. Low BMI and, indirectly, body weight also proved to be independent predictors of morbidity and mortality after RP for patients with chronic obstructive pulmonary disease and predictors of unfavorable outcome.
20
The exact mechanism of weight loss in patients with emphysema is not known, and there is no general agreement as to whether this is due mainly to FFM depletion. Several hypotheses have been formulated, including chronic inflammation from bronchial infection, loss of muscle strength associated with aging, inactivity, and steroid administration.
1,2 Creutzberg and colleagues
21 recently identified a group of patients without response to high-energy nutrition and hypothesized a multifactorial mechanism, including anorexia, shifting in body water compartments, inflammatory mediators, and hypoxia.
We believe one of the more likely explanations to be the elevated oxygen cost of breathing.
3-5,22 Such condition might be sustained by lung hyperinflation
9,19 and loss in lung elastic recoil,
23 causing an unfavorable length-tension relationship in the respiratory muscles.
Christensen and colleagues
8 have recently tried to correlate changes in body weight with respiratory functional indices. They showed that weight gain was not correlated significantly with either improvement in lung mechanics or decrease in lung volumes, whereas it was correlated with improvement in gas exchanges, as measured by diffusing capacity. Engelen and associates
24 showed that the best predictor of FFM depletion in patients with COPD in stable condition is the diffusing capacity. Furthermore, in a recent article Nezu and coworkers
25 demonstrated that bilateral RP results in FFM gain in underweight patients, and they explained this as the result of an increment in tissue oxygen delivery related to reduction in breathing workload.
According to our findings, only RP was capable of improving nutritional status, as proved by significant changes in body composition and biochemical markers (Table 3
) despite the substantial stability of energy intake and diet habits. No correlation was evident between nutritional markers and functional, exercise, and subjective indicators (Table 4
). No significant changes in energy intake and diet composition were found before and after treatment, thus supporting the theory of an increased energy cost in patients with emphysematous, hyperinflated lungs, who can regain weight after RP.
To our knowledge this is the first randomized controlled study, to investigate the relative impacts of RP and RR on body weight and nutritional status. However, the strict selection criteria, difficulty in randomization acceptance, and the crossover design probably limit the sample size available for long-term follow-up. One further limit might be represented by the heterogeneity of the RP group, which included patients treated by unilateral and bilateral procedures. We did perform intentional unilateral and bilateral RP according to precise radiologic morphologic criteria for emphysema.
15 The fact that we found no significant differences in weight gain when comparing the results achieved with unilateral and bilateral RP is consistent with our belief that both procedures have precise elective indications.
Patients with malnutrition related to emphysema were able to gain body weight after undergoing RP, mainly as a result of FFM increment, and to improve nutritional status within 6 months after the surgery, whereas no change was detectable in patients who had RR alone. Weight gain in patients after RP was linearly correlated with reduction of RV. Further investigation with more detailed metabolic assessment entailing basal and dynamic calorimetric measurements may give us much better insight into the complex interactions that result in weight loss and malnutrition in patients with emphysema.
| Appendix |
|---|
|
|
|---|
Ospedale "Cartoni" Rocca Priora, Italy: Mario Marino, Giuseppe Matteucci, and Filippo DePadova
Dept. Medicina Sperimentale e Patologia Università "La Sapienza," Rome, Italy: Italo Nofroni
Istituto Nazionale della Nutrizione, Rome, Italy: Angela Polito
Ospedale S. Eugenio, Rome, Italy: Mauro Polzoni and Franco Turani, Anestesia e Rianimazione; Gaetano Aiello and Paola Codato, Fisiopatologia Respiratoria; Nello Giovannone and Gianpaolo Giovannone, Dietologia; Luca Piantoni, Endocrinologia; Cesidio Cipriani and Sergio Boemi, Medicina Nucleare
Ospedale Civile di Frascati, Italy: Luigi Casella.
Ospedale "S. Giuseppe" Marino: Franz Finocchio Thorel
Ospedale "Calai," Gualdo Tadino, Italy: Marcello Paci
Ospedale Civile di Agnone, Italy: Nicola Iavicoli
Ospedale Civile di Lecce, Italy: Corrado Sorrenti and Gaetano Greco
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Mineo, V. Ambrogi, L. Frasca, M. E. Cufari, E. Pompeo, and T. C. Mineo Effects of Lung Volume Reduction Surgery for Emphysema on Glycolipidic Hormones Chest, July 1, 2008; 134(1): 30 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pompeo and T. C. Mineo Two-Year Improvement in Multidimensional Body Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index After Nonresectional Lung Volume Reduction Surgery in Awake Patients Ann. Thorac. Surg., December 1, 2007; 84(6): 1862 - 1869. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, E. Pompeo, D. Mineo, V. Ambrogi, D. Ciarapica, and A. Polito Resting energy expenditure and metabolic changes after lung volume reduction surgery for emphysema. Ann. Thorac. Surg., October 1, 2006; 82(4): 1205 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, V. Ambrogi, D. Mineo, A. Fabbri, E. Fabbrini, and R. Massoud Bone Mineral Density Improvement After Lung Volume Reduction Surgery for Severe Emphysema Chest, June 1, 2005; 127(6): 1960 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.C. Mineo, V. Ambrogi, E. Pompeo, S. Elia, D. Mineo, P. Bollero, and I. Nofroni Impact of lung volume reduction surgery versus rehabilitation on quality of life Eur. Respir. J., February 1, 2004; 23(2): 275 - 280. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |